Frank Karbe
Frank Karbe has over 25 years of financial and life-sciences expertise and helped build companies that successfully developed and commercialized multiple products. He also has a long standing passion for the intersection of medical science and digital technology and how it may be applied to improve human health. Prior to Better Therapeutics, he was President and Chief Financial Officer of Myovant Sciences where he led the company's efforts to raise approximately $2 billion in capital and its evolution from a private start-up organization to a publicly listed commercial stage company with two marketed products. He also served as Executive Vice President and Chief Financial Officer at Exelixis, Inc. for over a decade, as the company evolved from a discovery to a commercial organization. Earlier in his career, Mr. Karbe worked as an investment banker for Goldman Sachs & Co. focusing on corporate finance and mergers and acquisitions in the life sciences industry. Mr. Karbe holds a Diplom-Kaufmann (MBA) from the WHU Otto Beisheim School of Management in Koblenz, Germany.